These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 25643615)

  • 1. Transcription factor-mediated reprogramming: epigenetics and therapeutic potential.
    Firas J; Liu X; Lim SM; Polo JM
    Immunol Cell Biol; 2015 Mar; 93(3):284-9. PubMed ID: 25643615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming cell fates: insights from combinatorial approaches.
    Pereira CF; Lemischka IR; Moore K
    Ann N Y Acad Sci; 2012 Aug; 1266():7-17. PubMed ID: 22901251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Reprogramming of Somatic Cells for Regenerative Medicine.
    Xie M; Tang S; Li K; Ding S
    Acc Chem Res; 2017 May; 50(5):1202-1211. PubMed ID: 28453285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reprogramming of somatic cells. Problems and solutions].
    Schneider TA; Fishman VS; Liskovykh MA; Ponamartsev SV; Serov OL; Tomilin AN; Alenina N
    Tsitologiia; 2014; 56(12):869-80. PubMed ID: 25929128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High throughput sequencing identifies an imprinted gene, Grb10, associated with the pluripotency state in nuclear transfer embryonic stem cells.
    Li H; Gao S; Huang H; Liu W; Huang H; Liu X; Gao Y; Le R; Kou X; Zhao Y; Kou Z; Li J; Wang H; Zhang Y; Wang H; Cai T; Sun Q; Gao S; Han Z
    Oncotarget; 2017 Jul; 8(29):47344-47355. PubMed ID: 28476045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic Control of Reprogramming and Transdifferentiation by Histone Modifications.
    Qin H; Zhao A; Zhang C; Fu X
    Stem Cell Rev Rep; 2016 Dec; 12(6):708-720. PubMed ID: 27623868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simpler twist of fate.
    Eisenstein M
    Nature; 2016 Jun; 534(7607):421-3. PubMed ID: 27306187
    [No Abstract]   [Full Text] [Related]  

  • 8. Somatic cell reprogramming as a tool for neurodegenerative diseases.
    Ebrahimi A; Keske E; Mehdipour A; Ebrahimi-Kalan A; Ghorbani M
    Biomed Pharmacother; 2019 Apr; 112():108663. PubMed ID: 30970509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
    Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
    Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of Modified mRNA in Somatic Reprogramming to Pluripotency and Directed Conversion of Cell Fate.
    Wang AYL
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering cell fate: Spotlight on cell-activation and signaling-directed lineage conversion.
    Ebrahimi B
    Tissue Cell; 2016 Oct; 48(5):475-87. PubMed ID: 27514850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of small molecules on cell reprogramming.
    Baranek M; Belter A; Naskręt-Barciszewska MZ; Stobiecki M; Markiewicz WT; Barciszewski J
    Mol Biosyst; 2017 Jan; 13(2):277-313. PubMed ID: 27918060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming.
    Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N
    Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic memory in somatic cell nuclear transfer and induced pluripotency: evidence and implications.
    Firas J; Liu X; Polo JM
    Differentiation; 2014 Jul; 88(1):29-32. PubMed ID: 25281282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transient acquisition of pluripotency during somatic cell transdifferentiation with iPSC reprogramming factors.
    Maza I; Caspi I; Zviran A; Chomsky E; Rais Y; Viukov S; Geula S; Buenrostro JD; Weinberger L; Krupalnik V; Hanna S; Zerbib M; Dutton JR; Greenleaf WJ; Massarwa R; Novershtern N; Hanna JH
    Nat Biotechnol; 2015 Jul; 33(7):769-74. PubMed ID: 26098448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular Reprogramming in Basic and Applied Biomedicine: The Dawn of Regenerative Medicine.
    Dean W
    Methods Mol Biol; 2015; 1330():3-13. PubMed ID: 26621584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell reprogramming: Therapeutic potential and the promise of rejuvenation for the aging brain.
    López-León M; Outeiro TF; Goya RG
    Ageing Res Rev; 2017 Nov; 40():168-181. PubMed ID: 28903069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fusion of Reprogramming Factors Alters the Trajectory of Somatic Lineage Conversion.
    Velychko S; Kang K; Kim SM; Kwak TH; Kim KP; Park C; Hong K; Chung C; Hyun JK; MacCarthy CM; Wu G; Schöler HR; Han DW
    Cell Rep; 2019 Apr; 27(1):30-39.e4. PubMed ID: 30943410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-fusion-mediated reprogramming: pluripotency or transdifferentiation? Implications for regenerative medicine.
    Sanges D; Lluis F; Cosma MP
    Adv Exp Med Biol; 2011; 713():137-59. PubMed ID: 21432018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemically Induced Reprogramming of Somatic Cells to Pluripotent Stem Cells and Neural Cells.
    Biswas D; Jiang P
    Int J Mol Sci; 2016 Feb; 17(2):226. PubMed ID: 26861316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.